Biogen Idec has announced launch plans in India for Tecfidera (dimethyl fumarate) – the first oral therapy for remitting multiple sclerosis (RRMS) in the country.
Biogen's Indian affiliate said that it received approval for the product from the Drugs Controller General of India and that...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
